Tom 1, Nr 3 (2023)
List do Redakcji
Opublikowany online: 2024-01-05
Wyświetlenia strony 368
Wyświetlenia/pobrania artykułu 3

Eksport do Mediów Społecznościowych

Eksport do Mediów Społecznościowych

Mezoterapia dutasterydem w leczeniu łysienia androgenowego

Jakub Kobiałka1, Ugo Giordano2
Dermatologia w Praktyce Klinicznej 2023;1(3):120-122.

Streszczenie

Brak

Artykuł dostępny w formacie PDF

Dodaj do koszyka: 49,00 PLN

Posiadasz dostęp do tego artykułu?

Referencje

  1. Reguero Del Cura L, De Quintana Sancho A, Rubio Lombraña M, et al. Two cases of paradoxical nonscarring alopecia after mesotherapy with dutasteride. Skin Appendage Disord. 2022; 8(1): 46–48.
  2. Herz-Ruelas ME, Álvarez-Villalobos NA, Millán-Alanís JM, et al. Efficacy of intralesional and oral dutasteride in the treatment of androgenetic alopecia: a systematic review. Skin Appendage Disord. 2020; 6(6): 338–345.
  3. Almohanna HM, Perper M, Tosti A. Safety concerns when using novel medications to treat alopecia. Expert Opin Drug Saf. 2018; 17(11): 1115–1128.
  4. Moftah N, Mubarak R, Abdelghani R. Clinical, trichoscopic, and folliscopic identification of the impact of metabolic syndrome on the response to intradermal dutasteride 0.02% injection in patients with female pattern hair loss: a prospective cohort study. J Dermatolog Treat. 2021; 32(7): 827–836.
  5. Alsalhi W, Alalola A, Randolph M, et al. Novel drug delivery approaches for the management of hair loss. Expert Opin Drug Deliv. 2020; 17(3): 287–295.
  6. Vineetha Re, Jyothi M, Venkatesh D, et al. Mesotherapy in face. International J Res Engineering, Sci Manag. 2019; 2(10): 822–829.
  7. Abdallah MA, El-Zawahry KA, Besar H. Mesotherapy using dutasteride-containing solution in male pattern hair loss: a controlled pilot study. J Pan Arab Leag Dermatol. 2009; 20: 137–145.
  8. Saceda-Corralo D, Rodrigues-Barata AR, Vañó-Galván S, et al. Mesotherapy with dutasteride in the treatment of androgenetic alopecia. Int J Trichology. 2017; 9(3): 143–145.
  9. Sobhy N, Aly H, Shafee AEl, et al. Evaluation of the effect of injection of dutasteride as mesotherapeutic tool in treatment of androgenetic alopecia in males. Our Dermatology Online. 2013; 4(1): 40–45.
  10. Moftah N, Moftah N, Abd-Elaziz G, et al. Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation. J Eur Acad Dermatol Venereol. 2013; 27(6): 686–693.
  11. Saceda-Corralo D, Moustafa F, Moreno-Arrones Ó, et al. Mesotherapy with dutasteride for androgenetic alopecia: a retrospective study in real clinical practice. J Drugs Dermatol. 2022; 21(7): 742–747.
  12. Magdaleno-Tapial J, Valenzuela-Oñate C, García-Legaz-Martínez M, et al. Angioedema-like contact dermatitis caused by mesotherapy with dutasteride. Contact Dermatitis. 2020; 83(3): 246–247.